Active Nanotargeting in Medicine

Author(s): Piera Di Martino.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 17 , 2019


[1]
García-Couce J, Almirall A, Fuentes G, Kaijzel E, Chan A, Cruz LJ. Targeting polymeric nanobiomaterials as a platform for cartilage tissue engineering. Curr Pharm Des 2019; 25(17): 1915-32.
[2]
Gigliobianco MR, Di Martino P, Deng S, Casadidio C, Censi R. New advanced strategies for the treatment of lysosomal diseases affecting the central nervous system. Curr Pharm Des 2019; 25(17): 1933-50.
[3]
Gaspar N, Zambito G, Löwik CMWG, Mezzanotte L. Active targeting of macrophages. Curr Pharm Des 2019; 25(17): 1951-61.
[4]
Iscaro A, Howard NF, Muthana M. Nanoparticles: properties and applications in cancer immunotherapy. Curr Pharm Des 2019; 25(17): 1962-79.
[5]
Patras L, Banciu M. Intercellular crosstalk via extracellular vesicles in tumor milieu as emerging therapies for cancer progression. Curr Pharm Des 2019; 25(17): 1980-2006.
[6]
Ding Y, Hong X, Liu Y, Zhang H. Recent advances in magnetic upconversion nanocomposites for bioapplications. Curr Pharm Des 2019; 25(17): 2007-15.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 17
Year: 2019
Page: [1913 - 1914]
Pages: 2
DOI: 10.2174/138161282517190822161247

Article Metrics

PDF: 13
HTML: 2
PRC: 1

Special-new-year-discount